Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Vandana Singh

Natera Clocks 28% Jump In Q1 Sales, Lifts FY22 Guidance

  • Natera Inc (NASDAQ:NTRAgenerated Q1 revenues of $194.1 million, up 27.5% Y/Y, beating the consensus of $176.60 million.
  • Product revenues were $190.0 million, an increase of 57.8%.
  • The company processed approximately 489,300 tests, compared to approximately 348,200 tests in Q1 FY21.
  • The gross profit margin compressed to 46.8% from 56.1%, primarily due to the revenue recognition of approximately $28.6 million in the first quarter of 2021 due to the conclusion of its collaboration with Qiagen N.V (NYSE:QGEN).
  • At March 31, 2022, Natera held approximately $752.2 million in cash, cash equivalents, short-term investments, and restricted cash.
  • The company posted a Q1 EPS loss of $(1.45) compared to $(0.74) a year ago, beating the consensus of $(1.48).
  • Guidance: Natera anticipates FY22 sales of $790 million - $810 million, higher than the $770 million - $790 million expected earlier, compared to the consensus of $779.92 million.
  • 2022 gross margin to be approximately 46% to 48% of revenues
  • Price Action: NTRA shares are up 4.16% at $35.52 during the market session on the last check Friday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.